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April 20101070 Abstractsclaudication or chronic limb ischemia (CLI). Patients were monitored
clinically and with noninvasive laboratory testing for 30 months. Primary,
primary-assisted, and secondary patency and limb salvage were the primary
end points. Lesion location and length were evaluated for both groups.
Statistical analysis was performed using Kaplan-Meier and log-rank tests.
Results: Between 2004 and 2009, 984 lesions were analyzed in 407
patients (172 women and 235 men), of which 511 lesions were treated with
primary PTA and 473 were treated with PTAStent. There was no statistical
difference between the lesion distribution and characteristics of the PTA-
alone and PTAStent groups based on gender. The primary, primary-
assisted, secondary patency, and limb salvage in women treated with PTA
alone was significantly improved (P  .005) at all time points compared
with men undergoing PTA alone (Table). Outcomes after PTAStent for
men and women were similar for primary, primary-assisted, and secondary
patency at all intervals. Men had an improvement when PTAStent was
compared with PTA alone at all time intervals and patencies (P  .05).
There was also a statistically significant advantage for limb salvage in women
treated with PTA compared with men.
Conclusions: Women have significantly improved primary, primary-
assisted, secondary patency, and limb salvage rates compared with men after
treatment with PTA, and this should be the primary endovascular treatment
option for women; however, men may be better managed with primary
PTAStent. Table.
Postprocedural Duplex-calculated Blood Flow Measurements Corre-
late to Stent Patency at 12 Months
Ankur Chandra, MD,a Peter F. Lawrence, MD,b and Brian G. DeRubertis,
MD,b Division of Vascular Surgery, Ronald Regan University of California
Los Angeles (UCLA) Medical Center, Los Angeles, Califa; and Division of
Vascular Surgery, Ronald Regan UCLA Medical, Los Angeles, Calif, USAb
Objective: The utility of duplex surveillance of arterial stents has been
controversial, primarily aimed at detecting in-stent restenosis. Although veloc-
ities are commonly reported, they do not represent blood flow. The patency of
arterial prostheses is flow-dependant. We performed a preliminary evaluation of
consecutive patients to determine if postprocedural duplex-calculated blood
flows through stents correlate with 12-month primary patency.
Methods: Consecutive patients undergoing arterial stent placement
were retrospectively reviewed. Information regarding demographics, co-
morbidities, stent size, postprocedural duplex information, and 12-month
patency were recorded. Blood flow was calculated using duplex velocities
and stent dimensions.
Results: The study comprised 27 consecutive patients (age, 72.6 14
years, 14 men) with 35 stents (18 iliofemoral, 10 carotid, and 7 subclavian/Fig.mesenteric). Mean time from the procedure to the duplex study was 47 days.
At 12 months, 20 stents were primarily patent (PP) and 15 were secondarily
patent (SP). There was a significant difference between the PP and SP groups
with respect to initial in-stent mean velocities (92.5 cm/s PP vs 43.7 cm/s
SP, P .002;) and calculated flows (1918 mL/min PP vs 722 mL/min SP,
P .0001).With these threshold values, calculated flows had corresponding
sensitivity, specificity, and accuracy of 92%, 82%, and 86.2%, respectively, for
predicting stent patency, whereas those for velocity measurements were
lower at 83%, 71%, and 76%, respectively. Receiver operating characteristic
(ROC) curve (Fig) analysis showed a significantly greater area under the
curve for calculated flows compared with velocity measurements (0.965 vs
0.859, P  .001).
Conclusions: Calculated blood flows from an initial postprocedural
duplex study accurately correlate to stent patency at 12 months. By ROC
analysis, velocities alone were less sensitive, less specific, and less accurate.
This preliminary findingmandates prospective analysis of this technique with
individual vascular beds and larger patient populations. A clinical protocol
guiding stent surveillance and decisions for early reintervention is suggested.
Limitations of Re-entry Devices in Lower Extremity Chronic Total
Occlusions
Susanna H. Shin, MD, Donald Baril, MD, Rabih Chaer, MD, Robert Rhee,
MD, Michel Makaroun, MD, and Luke Marone, MD, University of Pitts-
burgh Medical Center, Pittsburgh, Pa, USA
Objective: Subintimal recanalization for the treatment of chronic total
occlusions (CTO) occasionally requires re-entry devices to access the true
lumen distally. Limited information is available on factors predicting the
success or failure of these devices.
Methods: All CTO cases from August 2006 to August 2009 were
retrospectively reviewed. Age, gender, occlusion length, site of re-entry, and
the angle of the aortic bifurcation were recorded. A calcification score (none,
mild, moderate, severe) at the re-entry site was assigned based on procedural
angiograms. Univariate and multivariate logistic regression analyses were
used to identify factors predicting failure of re-entry into the true lumen. The
Outback LTD re-entry device (Cordis) was used in all cases.
Results: Of 249 CTOs treated, the re-entry device was used 52 times
(20.9%), comprising 47 superficial femoral artery (SFA) occlusions and 5
combined SFA and popliteal artery occlusions (33 TransAtlantic Intersociety
Consensus II type C and 18 type D lesions). Of 48 procedures with available
angiograms for review, the target re-entry site was at the adductor canal in 30
(62.5%), the above-knee popliteal artery in 13 (27.1%), the behind the knee
joint in 4 (8.3%), and the mid-SFA in 2 (4.2%). The mean age was 73.1 years
(54.0% men). Re-entry was successful in 34 attempts (64.5%). Causes of
failure included inability to re-enter the true lumen in 11 (61.1%), difficulty
tracking the device over a wire in 3 (16.7%), acute angle of aortic bifurcation
in 2 (11.1%), mechanical failure of the device in 1 (5.6%), and difficulty
tracking the device through the lesion in 1 (5.6%). Moderate or severe
calcification at the site of re-entry was the only significant predictor of failure
(odds ratio, 6.3; P  .01). An aortic bifurcation angle 40° did trend
toward predicting success (odds ratio, 0.23; P  .54).
Conclusions: Although re-entry devices can be successful in extending
the applicability of endovascular management to difficult femoropopliteal
occlusions, they are not uniformly successful in current clinical practice.
Significant calcification at the proposed re-entry site is a strong predictor of
failure.
Infrageniculate Interventions in Female Patients: Improved Patency
Rates but Higher Rates of Postoperative Complications
Tejas R. Shah, MD, Angeliki Vouyouka, MD, Daniel K. Han, BA, Sharif
Ellozy, MD, Robert Lookstein, MD, Prasad Shirvalkar, MS, Michael Marin,
MD, and Peter L. Faries, MD,Mount Sinai Medical Center, New York, NY,
USA
Introduction: Infrageniculate arterial disease is increasingly treated
with endovascular management as an alternative to open surgery. Although
previous studies have analyzed the effect of gender on the success of other
arterial interventions, little is known about outcomes of infrageniculate
interventions between men and women.
Methods: Infrageniculate interventions were retrospectively reviewed
in a prospectively maintained database from 1999 to 2009. Primary end
points included technical success, limb salvage, primary patency, and sec-
ondary patency rates. Secondary end points included access site complica-
tions (ie, hematoma, thrombosis) and systemic complications (ie, myocar-
dial infarction, death).Results: Between July 1999 and November 2009, 329 tibial lesions
were treated in 277 patients, comprising 152 men (mean age, 71.4  13.1
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more likely to undergo treatment for critical limb ischemia (87.7% vs 77.7%;
P .028) and less likely to have treatment for claudication (12.3% vs 22.3%;
P  NS). Women were also more likely to undergo balloon angioplasty
(57.5% vs 68.9%; P  .043). However, men were more likely to have
coronary disease, history of coronary bypass grafting, and chronic renal
insufficiency. TransAtlantic Intersociety Consensus distribution, incidence
of smoking, and diabetes were equivalent in both sexes. When adjusted for
comorbidities, women had higher 24-month primary patency rates
(46.0% 6.1% vs 30.4% 5.9%; P .016) and limb salvage rates (87.5%
4.1% vs 82.9% 5.4%; P .041) than men for tibial lesions with concurrent
proximal disease. The difference in 24-month patency between women and
men was more pronounced for isolated tibial lesions (50.1% 10.1% vs
28.8%  10.4%; P  .002). Although the overall complication rates were
similar, women had comparatively higher rates of postoperative access site
thrombosis than men (8.9% vs 0.6%, P  .001).
Conclusions: Overall, endovascular interventions below the knee are
safe and effective in women and should be considered the first-line modality
for the management of critical tibial occlusive disease. However, further
investigation and development of technique to better fit the female anatomy
is necessary to improve the gender-related disparity in access site-related
complications.
TheMinimally InvasiveManagement of Visceral Artery Aneurysms and
Pseudoaneurysms
Grant T. Fankhauser, MD,a William M. Stone, MD,a Sailendra G. Naidu,
MD,a Gustavo S. Oderich, MD,b Joseph J. Ricotta II, MD,b and Haraldur
Bjarnason, MD,b Mayo Clinic Arizona, Scottsdale, Ariza; and Mayo Clinic,
Rochester, Minn, USAb
Objective: Minimally invasive endovascular and percutaneous meth-
ods are now available for the management of visceral artery aneurysms and
pseudoaneurysms. This study reviewed our 10-year experience with the
minimally invasive treatment of visceral artery aneurysms.
Methods: The review included all patients evaluated from June 1999
to June 2009 with the diagnosis of aneurysms of the celiac, superior
mesenteric, and inferior mesenteric arteries and their branches. Medical
records were reviewed for demographics, therapy, and results.
Results: Minimally invasive management was attempted in 185
aneurysms in 176 patients (56% men; mean age, 58 years). Intervention
was successful in 182 of 185 (98%) aneurysms in 173 patients. Sixty-three
(34%) aneurysms were located in the splenic artery, 56 (30%) in the
hepatic artery, 28 (15%) in the gastroduodenal, 16 (8.6%) in the pancre-
aticoduodenal, 6 (3.2%) in the superior mesenteric, 4 (2.1%) in the
gastric, 4 (2.1%) in the celiac, 4 (2.1%) in the gastroepiploic, 2 (1%) in the
inferior mesenteric, and 1 (0.5%) in the middle colic artery. Pseudoan-
eurysms were more common than true aneurysms (64% vs 36%). Acute
bleeding was the indication for intervention in 86 aneurysms (46%).
Initial treatment was successful in 177 aneurysms (96%). Five aneurysms
(3%) required additional intervention 30 days for persistent flow or
bleeding. Coiling was the sole technique used in 139 aneurysms (75%)
and was combined with at least one other technique in 20 other aneu-
rysms (11%). Thirty-day aneurysm-related mortality was 1% (2 deaths).
Nine (4.8%) additional deaths occurred during the 30-day follow-up, but
none were related to complications of the aneurysms.
Conclusions: Minimally invasive intervention for visceral artery aneu-
rysms can be used alone or in combination to effectively treat these aneu-
rysms in elective or emergency conditions.
Our Experience with 140 Visceral Artery Stents: Should Celiac Artery
Stenting be Abandoned?
Tyler J. Dahl, BBmE, Christopher L. Stout, MD, William N. Veale, MD,
Brian L. Chen, MD, Jarrod D. Day, MD, Cory A. Messerschmidt, BS, and
Jean M. Panneton, MD, Eastern Virginia Medical School, Norfolk, Va,
USA
Objective: Open bypass is the gold standard treatment for mesenteric
ischemia.With the refinement of endovascular therapy, visceral stenting is an
attractive minimally invasive alternative but has limited data, and which
vessel(s) respond best to stenting has not been addressed. This study
compared the outcomes of superior mesenteric artery (SMA) and celiac
artery (CA) stenting.Methods: All consecutive patients who received visceral stenting
between January 2002 and May 2009 were reviewed. Standard statisticalanalysis, including Kaplan-Meier, was performed. Primary patency was
defined as a peak systolic velocity350 cm/s for the CA and450 cm/s
for the SMA. A stenosis of50% at arteriography was considered a loss of
primary patency.
Results: Visceral stents were placed in 140 patients: SMA in 92
(65.7%), CA in 40 (28.6%), and inferior mesenteric artery in 8 (5.7%). There
were 29men (20.7%) and 111 women (79.3%) with amean age of 72.9 years
(range, 20.5-93.9 years). Mean follow-up was 12.8 months. Technical
success was 100% for all. The 30-day mortality rate was 0% for the SMA and
5% for the CA. One-year primary patency was 55% for the SMA and 17% for
the CA (P  .0001). Loss of CA primary patency was associated with
ischemic heart disease (P .05), stent diameter of6 mm (P .042), and
age 50 years (P  .038). These factors did not correlate with loss of
primary patency for the SMA (Fig).
Conclusions: Visceral stenting has an exceptional technical success
rate, with low procedural mortality. Primary patency of the SMA group
was significantly higher than that for the CA. Our data suggest that CA
stenosis, especially in young patients and those with small vessels, does
not respond well to stenting. Therefore, the practice of celiac artery
stenting should be abandoned.
Ten-year Experience with Renal Artery In-stent Restenosis
Patrick A. Stone, MD, and Ali F. Aburahma, MD, West Virginia University,
Charleston, WV, USA
Objective: Endovascular interventions for symptomatic renal artery
stenosis have become the first-line treatment. Limited data are available for
the long-term outcome of secondary interventions of recurrent renal artery
stenosis after stenting.
Methods:This was a retrospective analysis of a 10-year experience with
percutaneous renal artery interventions. Only patients presenting with re-
current symptomatic stenosis were reviewed. End points analyzed included
freedom from tertiary procedures, a decrease in baseline renal function
20%, patency confirmed by duplex imaging, freedom from hemodialysis,
and patient survival.
Results: The review included 948 patients with 1150 renal arteries
treated; of these, 123 arteries in 108 patients (68.9% women) presented with
symptomatic recurrent stenosis, comprising recurrent hypertension in 97%
and renal insufficiency in 67%. The average age was 68.9. Mean follow-up
was 30 months (range, 1.2-104.7 months) for patency and 56 months
(range, 6.2-112.7 months) for creatinine level. Secondary interventions
included percutaneous transluminal angioplasty (PTA) only in 27, PTAwith
cutting balloon in 9, repeat renal artery stenting in 80, and drug-eluting
stent (DES) placement in 7. After secondary interventions, 20 of the 123
arteries (16.3%) in 18 patients required tertiary interventions. Freedom from
tertiary interventions was similar among treatment modalities, with PTA,
PTA-cutting balloon, stent, and DES groups having 81.5%, 100%, 83.8%,
and 71.4%, respectively, of patients remaining procedure free. Forty patients
(37%) had a decrease in renal function 20%, and 24 (22.2%) remained or
Fig.progressed to renal failure (estimated glomerular filtration rate 30%), and
eight ultimately required hemodialysis. Patient survival was 72.8% at 5 years.
